JPRN-UMIN000019556已完成未知
Hormonal therapy resistant estorgen receptor positive metastatic breast cancer cohort study - HORSE-BC
General Incorporated Association of CSPOR-BC0 个研究点目标入组 200 人开始时间: 2015年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •A case that corresponds to any of the following is excluded from participating in this study as a subject. (1)HER2-positive breast cancer. (2)A case not indicated for endocrine therapy. (3)Any other case that a physician determines to be unsuitable for participation in this study.
研究者
相似试验
已完成
不适用
Clinical Trial of a Selective Estrogen Receptor Modulator (raloxifene) in Schizophreniacognitive deficits in patients with schizophreniapsychotic symptoms in patients with schizophreniaMental Health - SchizophreniaACTRN12608000461392niversity of New South Wales80
招募中
3 期
Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial.
LEPRE Trial2024-516874-31-00Ente Ospedaliero Ospedali Galliera Di Genova132
招募中
不适用
Gonadotropin-releasing hormone (GnRH) agonist for prevention of chemotherapy induced menopause in malignant ovarian germ cell tumor: a multicenter studyDiseases of The genitoruinary systemKCT0003286Bundang CHA General Hospital65
尚未招募
Unknown
Evaluating utility of Oestrogen and Progesterone Receptor biomarkers for prediction of colorectal CancerCTRI/2024/05/068054Datta Meghe Institute of Higher Education & Research (DMIHER)
招募中
3 期
Chemotherapy or chemotherapy + hormonotherapy in women over 70 with HER2 receptor-negative but estrogen receptor-positive breast cancer according to their genomic grade2024-516996-34-00Unicancer1,989